Tumor TF expression (H‐score) was generally comparable between the first and second biopsy in patients with cervical, ovarian, and prostate cancer (Figure 3A,B), although differences in H‐score were observed between T1 and T2 for individual patients. This evidence concerns the gene TF and prostate carcinoma.